Joshua Hamermesh serves as Executive at Molecular Insight Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Joshua Hamermesh has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 31, 2008 involved exercising options for 4,166 shares valued at $12.5K.
Joshua Hamermesh currently holds 20,833 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Hamermesh has been a net neutral trader of MIPI stock. They have purchased $0 and sold $0 worth of shares.
Joshua Hamermesh's most recent insider trade was on Mar 31, 2008, when they sold 4,166 shares at $3.00 per share.
Get notified when new Form 4 filings are submitted
| 8,334 |
| $3.00 |
| Discretionary |
| Jun 19, 2007 | MIPI | $25.0K | Option Exercise | 8,333 | $3.00 | Discretionary |